Stegostoma fasciatum isolate 6-17 chromosome 13, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039239.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3
StAR-related lipid transfer (START) domain containing 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protocadherin-1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protocadherin-1-like, transcript variant X4
protocadherin-1-like, transcript variant X1
protocadherin-1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protocadherin-1-like, transcript variant X3
protocadherin-1-like, transcript variant X2
uncharacterized LOC125458078, transcript variant X1
uncharacterized LOC125458078, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein diaphanous homolog 1-like, transcript variant X1
protein diaphanous homolog 1-like, transcript variant X2
protein diaphanous homolog 1-like, transcript variant X3
protein diaphanous homolog 1-like isoform X1
protein diaphanous homolog 1-like isoform X2
protein diaphanous homolog 1-like isoform X3
protocadherin gamma-A11-like, transcript variant X5
protocadherin gamma-A11-like, transcript variant X3
protocadherin gamma-A11-like, transcript variant X4
protocadherin gamma-A11-like, transcript variant X2
protocadherin gamma-A11-like, transcript variant X6
protocadherin gamma-A11-like, transcript variant X1
protocadherin gamma-A11-like, transcript variant X7
protocadherin gamma-A11-like, transcript variant X9
protocadherin gamma-A11-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
protocadherin-10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protocadherin-10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protocadherin-10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X2
protocadherin alpha-C2-like, transcript variant X1
protocadherin alpha-C2-like, transcript variant X4
protocadherin alpha-C2-like, transcript variant X6
protocadherin alpha-C2-like, transcript variant X3
protocadherin alpha-C2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-C5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC100537710 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 147 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger, matrin-type 2, transcript variant X2
zinc finger, matrin-type 2, transcript variant X1
zinc finger matrin-type protein 2 isoform X2
zinc finger matrin-type protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
histidyl-tRNA synthetase, transcript variant X2
histidyl-tRNA synthetase, transcript variant X1
CRAL-TRIO domain-containing protein C3H8.02-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
NADH:ubiquinone oxidoreductase subunit A2, transcript variant X1
NADH:ubiquinone oxidoreductase subunit A2, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 isoform X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 isoform X2
transmembrane and coiled-coil domains 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 6 isoform X3
transmembrane and coiled-coil domain-containing protein 6 isoform X2
transmembrane and coiled-coil domains 6, transcript variant X1
transmembrane and coiled-coil domain-containing protein 6 isoform X1
chromosome-associated kinesin KIF4B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable UDP-sugar transporter protein SLC35A4
SLC35A4 upstream open reading frame protein
amyloid beta (A4) precursor protein-binding, family B, member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
amyloid beta (A4) precursor protein-binding, family B, member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
amyloid-beta A4 precursor protein-binding family B member 3 isoform X1
amyloid-beta A4 precursor protein-binding family B member 3 isoform X2
39S ribosomal protein L22, mitochondrial
gem (nuclear organelle) associated protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
gem (nuclear organelle) associated protein 5, transcript variant X2
TNFAIP3 interacting protein 1, transcript variant X9
TNFAIP3 interacting protein 1, transcript variant X6
TNFAIP3 interacting protein 1, transcript variant X5
TNFAIP3 interacting protein 1, transcript variant X4
TNFAIP3 interacting protein 1, transcript variant X2
TNFAIP3-interacting protein 1 isoform X2
TNFAIP3 interacting protein 1, transcript variant X1
TNFAIP3 interacting protein 1, transcript variant X10
TNFAIP3 interacting protein 1, transcript variant X3
TNFAIP3-interacting protein 1 isoform X1
TNFAIP3-interacting protein 1 isoform X5
TNFAIP3-interacting protein 1 isoform X3
TNFAIP3 interacting protein 1, transcript variant X7
TNFAIP3 interacting protein 1, transcript variant X8
TNFAIP3-interacting protein 1 isoform X4
protein NDNF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein NDNF-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
repetitive proline-rich cell wall protein 2-like
uncharacterized LOC125458369, transcript variant X2
uncharacterized LOC125458369, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X2
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X6
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X5
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X8
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1b, transcript variant X10
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1b
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00092
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X3
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X2
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CD74 molecule, major histocompatibility complex, class II invariant chain b, transcript variant X5
CD74 molecule, major histocompatibility complex, class II invariant chain b isoform X1
CD74 molecule, major histocompatibility complex, class II invariant chain b isoform X3
CD74 molecule, major histocompatibility complex, class II invariant chain b isoform X2
arylsulfatase family, member Ia, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
arylsulfatase family, member Ia, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
platelet-derived growth factor receptor, beta polypeptide
platelet-derived growth factor receptor beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane O-methyltransferase homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
transmembrane O-methyltransferase homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane O-methyltransferase homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane O-methyltransferase homolog isoform X1
transmembrane O-methyltransferase homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chemotaxis regulatory protein ChePep-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mastermind-like transcriptional coactivator 1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X2
MRN complex interacting protein, transcript variant X1
MRN complex-interacting protein isoform X1
MRN complex interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
MRN complex-interacting protein isoform X2
TBC1 domain family member 9B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
TBC1 domain family member 9B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
TBC1 domain family member 9B-like isoform X2
TBC1 domain family member 9B-like isoform X1
ring finger protein 130, transcript variant X2
ring finger protein 130, transcript variant X4
ring finger protein 130, transcript variant X1
E3 ubiquitin-protein ligase RNF130 isoform X4
E3 ubiquitin-protein ligase RNF130 isoform X2
E3 ubiquitin-protein ligase RNF130 isoform X1
ring finger protein 130, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ring finger protein 130, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF130 isoform X5
E3 ubiquitin-protein ligase RNF130 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
vascular endothelial growth factor receptor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
mast/stem cell growth factor receptor Kit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger HIT domain-containing protein 2
histone deacetylase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
histone deacetylase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
RELT-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RELT-like protein 2, transcript variant X1
RELT-like protein 2, transcript variant X3
F-BAR and double SH3 domains protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mediator of RNA polymerase II transcription subunit 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
hyaluronan-mediated motility receptor (RHAMM), transcript variant X1
hyaluronan-mediated motility receptor (RHAMM), transcript variant X2
hyaluronan mediated motility receptor isoform X1
hyaluronan mediated motility receptor isoform X2
methionine adenosyltransferase 2 subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LON peptidase N-terminal domain and RING finger protein 1-like
fatty acid hydroxylase domain containing 2, transcript variant X2
fatty acid hydroxylase domain containing 2, transcript variant X5
fatty acid hydroxylase domain containing 2, transcript variant X3
fatty acid hydroxylase domain containing 2, transcript variant X6
fatty acid hydroxylase domain containing 2, transcript variant X1
fatty acid hydroxylase domain containing 2, transcript variant X4
fatty acid hydroxylase domain-containing protein 2
La ribonucleoprotein 1, translational regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
La ribonucleoprotein 1, translational regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X4
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like
heart- and neural crest derivatives-expressed protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125458550, transcript variant X1
uncharacterized LOC125458550, transcript variant X2
uncharacterized LOC125458550, transcript variant X3
uncharacterized LOC125458550, transcript variant X4
uncharacterized LOC125458550, transcript variant X5
uncharacterized protein LOC125458550 isoform X1
uncharacterized protein LOC125458550 isoform X2
uncharacterized protein LOC125458550 isoform X3
uncharacterized protein LOC125458550 isoform X4
uncharacterized protein LOC125458550 isoform X5
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2-like isoform X2
prolyl 4-hydroxylase subunit alpha-2-like isoform X4
prolyl 4-hydroxylase subunit alpha-2-like isoform X1
prolyl 4-hydroxylase subunit alpha-2-like isoform X5
prolyl 4-hydroxylase subunit alpha-2-like isoform X3
prolyl 4-hydroxylase subunit alpha-2-like isoform X6
RAD50 homolog, double strand break repair protein, transcript variant X1
RAD50 homolog, double strand break repair protein, transcript variant X2
RAD50 homolog, double strand break repair protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 4, transcription factor 3
RNA binding motif protein 27, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RNA binding motif protein 27, transcript variant X1
RNA binding motif protein 27, transcript variant X2
RNA binding motif protein 27, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RNA binding motif protein 27, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
NEDD4 family-interacting protein 1, transcript variant X1
NEDD4 family-interacting protein 1, transcript variant X2
NEDD4 family-interacting protein 1 isoform X1
NEDD4 family-interacting protein 1 isoform X2
sprouty homolog 4 (Drosophila), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sprouty homolog 4 (Drosophila), transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
sprouty homolog 4 (Drosophila), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sprouty homolog 4 (Drosophila), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sprouty homolog 4 (Drosophila), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
sprouty homolog 4 (Drosophila), transcript variant X3
fibroblast growth factor 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 1-like isoform X2
fibroblast growth factor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fibroblast growth factor 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 21% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: cationic amino acid transporter 2-like
platelet-derived growth factor receptor-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
coiled-coil domain-containing protein 69-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 36 member 1, transcript variant X1
solute carrier family 36 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
proton-coupled amino acid transporter 1 isoform X1
proton-coupled amino acid transporter 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
protocadherin Fat 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protocadherin Fat 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protocadherin Fat 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
secreted protein, acidic, cysteine-rich (osteonectin)
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X5
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X4
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X3
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X2
GTPase activating protein (SH3 domain) binding protein 1, transcript variant X1
ras GTPase-activating protein-binding protein 1
glycine receptor, alpha 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glycine receptor, alpha 1, transcript variant X2
glycine receptor subunit alphaZ1 isoform X1
glycine receptor subunit alphaZ1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutaredoxin domain-containing cysteine-rich protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X1
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X4
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X5
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X2
E3 ubiquitin-protein ligase SH3RF2-like, transcript variant X3
E3 ubiquitin-protein ligase SH3RF2-like isoform X1
E3 ubiquitin-protein ligase SH3RF2-like isoform X2
E3 ubiquitin-protein ligase SH3RF2-like isoform X3
NudC domain containing 2, transcript variant X2
NudC domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
signal peptidase complex subunit 3-like, transcript variant X2
signal peptidase complex subunit 3-like, transcript variant X1
signal peptidase complex subunit 3-like isoform X1
signal peptidase complex subunit 3-like isoform X2
HMG box domain containing 3, transcript variant X6
HMG box domain containing 3, transcript variant X4
HMG box domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
HMG box domain containing 3, transcript variant X5
HMG box domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
HMG box domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
HMG domain-containing protein 3 isoform X1
HMG domain-containing protein 3 isoform X3
HMG domain-containing protein 3 isoform X2
HMG domain-containing protein 3 isoform X4
vascular endothelial growth factor C-like, transcript variant X2
vascular endothelial growth factor C-like, transcript variant X1
vascular endothelial growth factor C-like isoform X2
vascular endothelial growth factor C-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein KIBRA-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein KIBRA-like, transcript variant X2
arginyl-tRNA synthetase 1, transcript variant X1
arginyl-tRNA synthetase 1, transcript variant X2
arginine--tRNA ligase, cytoplasmic isoform X1
arginine--tRNA ligase, cytoplasmic isoform X2
rho GTPase-activating protein 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho GTPase-activating protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho GTPase-activating protein 7 isoform X1
rho GTPase-activating protein 7 isoform X2
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sarcoglycan, delta (dystrophin-associated glycoprotein), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger CCHC domain-containing protein 10
AF4/FMR2 family, member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
AF4/FMR2 family, member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
AF4/FMR2 family, member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
AF4/FMR2 family, member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
liver-expressed antimicrobial peptide 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome b-c1 complex subunit 8, transcript variant X2
cytochrome b-c1 complex subunit 8, transcript variant X3
cytochrome b-c1 complex subunit 8, transcript variant X4
cytochrome b-c1 complex subunit 8, transcript variant X1
protein Shroom1-like, transcript variant X2
protein Shroom1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein Shroom1-like, transcript variant X3
sosondowah ankyrin repeat domain family member Ab
ankyrin repeat domain-containing protein SOWAHA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ring finger protein 14, transcript variant X2
ring finger protein 14, transcript variant X1
E3 ubiquitin-protein ligase RNF14 isoform X1
ring finger protein 14, transcript variant X3
E3 ubiquitin-protein ligase RNF14 isoform X2
glucosamine-6-phosphate deaminase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glucosamine-6-phosphate deaminase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glucosamine-6-phosphate deaminase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glucosamine-6-phosphate deaminase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glucosamine-6-phosphate deaminase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glucosamine-6-phosphate isomerase 1 isoform X1
glucosamine-6-phosphate isomerase 1 isoform X2
glucosamine-6-phosphate isomerase 1 isoform X3
gamma-aminobutyric acid receptor subunit gamma-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit gamma-2-like isoform X1
gamma-aminobutyric acid receptor subunit gamma-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit gamma-2-like isoform X2
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X3
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X8
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X5
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X4
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X1
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X6
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X7
gamma-aminobutyric acid receptor subunit alpha-1-like isoform X1
gamma-aminobutyric acid receptor subunit alpha-1-like isoform X2
gamma-aminobutyric acid receptor subunit alpha-1-like isoform X3
gamma-aminobutyric acid receptor subunit alpha-1-like isoform X4
gamma-aminobutyric acid receptor subunit alpha-1-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha6b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha6b, transcript variant X2
gamma-aminobutyric acid type A receptor subunit alpha6b, transcript variant X5
gamma-aminobutyric acid type A receptor subunit alpha6b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha6b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha6b, transcript variant X3
gamma-aminobutyric acid receptor subunit alpha-6 isoform X2
gamma-aminobutyric acid receptor subunit alpha-6 isoform X4
gamma-aminobutyric acid receptor subunit alpha-6 isoform X3
gamma-aminobutyric acid receptor subunit alpha-6 isoform X1
gamma-aminobutyric acid receptor subunit alpha-6 isoform X5
gamma-aminobutyric acid receptor subunit beta-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phospholipid-transporting ATPase VB-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
phospholipid-transporting ATPase VB-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid-transporting ATPase VB-like, transcript variant X4
phospholipid-transporting ATPase VB-like, transcript variant X3
phospholipid-transporting ATPase VB-like isoform X2
phospholipid-transporting ATPase VB-like isoform X1
sorbin and SH3 domain-containing protein 2-like, transcript variant X1
sorbin and SH3 domain-containing protein 2-like, transcript variant X8
sorbin and SH3 domain-containing protein 2-like, transcript variant X10
sorbin and SH3 domain-containing protein 2-like, transcript variant X4
sorbin and SH3 domain-containing protein 2-like, transcript variant X2
sorbin and SH3 domain-containing protein 2-like, transcript variant X5
sorbin and SH3 domain-containing protein 2-like, transcript variant X6
sorbin and SH3 domain-containing protein 2-like, transcript variant X7
sorbin and SH3 domain-containing protein 2-like, transcript variant X9
sorbin and SH3 domain-containing protein 2-like, transcript variant X3
uncharacterized protein LOC125458562 isoform X1
uncharacterized protein LOC125458562 isoform X2
sorbin and SH3 domain-containing protein 2-like isoform X4
sorbin and SH3 domain-containing protein 2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125458166, transcript variant X3
uncharacterized LOC125458166, transcript variant X4
uncharacterized LOC125458166, transcript variant X1
uncharacterized LOC125458166, transcript variant X2
uncharacterized protein LOC125458166 isoform X1
uncharacterized protein LOC125458166 isoform X2
uncharacterized protein LOC125458166 isoform X3
solute carrier family 22 member 5-like, transcript variant X2
solute carrier family 22 member 5-like, transcript variant X1
solute carrier family 22 member 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 22 member 5-like isoform X1
solute carrier family 22 member 5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 22 member 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 22 member 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 22 member 4-like isoform X3
solute carrier family 22 member 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 22 member 5-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 22 member 5-like, transcript variant X4
solute carrier family 22 member 5-like isoform X4
solute carrier family 22 member 5-like isoform X3
interferon regulatory factor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
interferon regulatory factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X4
long-chain-fatty-acid--CoA ligase 6-like isoform X2
long-chain-fatty-acid--CoA ligase 6-like isoform X1
long-chain-fatty-acid--CoA ligase 6-like isoform X4
long-chain-fatty-acid--CoA ligase 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 6-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
folliculin interacting protein 1, transcript variant X1
folliculin interacting protein 1, transcript variant X2
folliculin-interacting protein 1 isoform X1
folliculin-interacting protein 1 isoform X2
folliculin interacting protein 1, transcript variant X3
folliculin-interacting protein 1 isoform X3
folliculin interacting protein 1, transcript variant X4
folliculin-interacting protein 1 isoform X4
uncharacterized LOC125458197, transcript variant X3
uncharacterized LOC125458197, transcript variant X2
uncharacterized LOC125458197, transcript variant X1
rap guanine nucleotide exchange factor 6-like, transcript variant X1
rap guanine nucleotide exchange factor 6-like, transcript variant X3
rap guanine nucleotide exchange factor 6-like, transcript variant X7
rap guanine nucleotide exchange factor 6-like, transcript variant X4
rap guanine nucleotide exchange factor 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rap guanine nucleotide exchange factor 6-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rap guanine nucleotide exchange factor 6-like isoform X1
rap guanine nucleotide exchange factor 6-like isoform X3
rap guanine nucleotide exchange factor 6-like isoform X7
rap guanine nucleotide exchange factor 6-like isoform X4
rap guanine nucleotide exchange factor 6-like isoform X2
rap guanine nucleotide exchange factor 6-like isoform X5
rap guanine nucleotide exchange factor 6-like, transcript variant X6
rap guanine nucleotide exchange factor 2-like isoform X6
rap guanine nucleotide exchange factor 6-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rap guanine nucleotide exchange factor 6-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rap guanine nucleotide exchange factor 6-like isoform X8
rap guanine nucleotide exchange factor 6-like isoform X9
follistatin-related protein 5-like, transcript variant X2
follistatin-related protein 5-like, transcript variant X4
follistatin-related protein 5-like, transcript variant X3
follistatin-related protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
follistatin-related protein 5-like isoform X3
follistatin-related protein 5-like isoform X2
follistatin-related protein 5-like isoform X1
keratinocyte-associated transmembrane protein 2-like, transcript variant X1
keratinocyte-associated transmembrane protein 2-like, transcript variant X2
keratinocyte-associated transmembrane protein 2-like isoform X1
keratinocyte-associated transmembrane protein 2-like isoform X2
voltage-dependent anion-selective channel protein 1
cytochrome P450 2U1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome P450 2U1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cytochrome P450 2U1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytochrome P450 2U1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cytochrome P450 2U1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transcription factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor 7, transcript variant X2
transcription factor 7, transcript variant X3
transcription factor 7, transcript variant X4
transcription factor 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor 7, transcript variant X9
transcription factor 7, transcript variant X5
transcription factor 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor 7, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor 7, transcript variant X8
S-phase kinase-associated protein 1, transcript variant X2
S-phase kinase-associated protein 1, transcript variant X1
S-phase kinase-associated protein 1, transcript variant X3
S-phase kinase-associated protein 1, transcript variant X4
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
ubiquitin-conjugating enzyme E2 A-like, transcript variant X1
ubiquitin-conjugating enzyme E2 A-like, transcript variant X2
ubiquitin-conjugating enzyme E2 A-like isoform X1
ubiquitin-conjugating enzyme E2 A-like isoform X2
CDKN2A interacting protein N-terminal like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
jade family PHD finger 2, transcript variant X3
jade family PHD finger 2, transcript variant X2
jade family PHD finger 2, transcript variant X1
jade family PHD finger 2, transcript variant X6
jade family PHD finger 2, transcript variant X5
jade family PHD finger 2, transcript variant X4
secretion associated, Ras related GTPase 1B
SEC24 homolog A, COPII coat complex component
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
calcium signal-modulating cyclophilin ligand
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46, transcript variant X1
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46, transcript variant X2
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46, transcript variant X3
DEAD (Asp-Glu-Ala-Asp) box polypeptide 46, transcript variant X4
probable ATP-dependent RNA helicase DDX46 isoform X1
probable ATP-dependent RNA helicase DDX46 isoform X2
probable ATP-dependent RNA helicase DDX46 isoform X3
probable ATP-dependent RNA helicase DDX46 isoform X4
chromosome 13 C5orf24 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromosome 13 C5orf24 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UPF0461 protein C5orf24 homolog isoform X1
UPF0461 protein C5orf24 homolog isoform X2
thioredoxin domain containing 15, transcript variant X1
thioredoxin domain-containing protein 15 isoform X1
thioredoxin domain containing 15, transcript variant X2
thioredoxin domain-containing protein 15 isoform X2
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X6
pterin-4-alpha-carbinolamine dehydratase 2-like isoform X6
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X3
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X1
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X4
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
pterin-4-alpha-carbinolamine dehydratase 2-like isoform X1
pterin-4-alpha-carbinolamine dehydratase 2-like isoform X3
uncharacterized protein LOC125458478 isoform X2
uncharacterized protein LOC125458478 isoform X4
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X5
pterin-4-alpha-carbinolamine dehydratase 2-like isoform X5
cation channel sperm-associated protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
paired-like homeodomain 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
paired-like homeodomain 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
paired-like homeodomain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
paired-like homeodomain 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
paired-like homeodomain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
paired-like homeodomain 1, transcript variant X7
paired-like homeodomain 1, transcript variant X6
core histone macro-H2A.1, transcript variant X3
core histone macro-H2A.1, transcript variant X1
core histone macro-H2A.1, transcript variant X2
solute carrier family 25 member 48, transcript variant X3
solute carrier family 25 member 48, transcript variant X1
solute carrier family 25 member 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 25 member 48, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 25 member 48 isoform X1
solute carrier family 25 member 48 isoform X2
solute carrier family 25 member 48 isoform X3
F-box/LRR-repeat protein 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
F-box/LRR-repeat protein 3-like, transcript variant X1
F-box/LRR-repeat protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
F-box/LRR-repeat protein 3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
F-box/LRR-repeat protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transforming growth factor, beta-induced, transcript variant X1
transforming growth factor, beta-induced, transcript variant X2
transforming growth factor-beta-induced protein ig-h3 isoform X1
transforming growth factor-beta-induced protein ig-h3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
BTB/POZ domain-containing protein KCTD16-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BTB/POZ domain-containing protein KCTD16-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD16-like isoform X2
BTB/POZ domain-containing protein KCTD16-like isoform X1
BTB/POZ domain-containing protein KCTD16-like, transcript variant X3
BTB/POZ domain-containing protein KCTD16-like isoform X3
Yip1 domain family, member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Yip1 domain family, member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC125458077, transcript variant X4
uncharacterized LOC125458077, transcript variant X3
uncharacterized LOC125458077, transcript variant X2
uncharacterized LOC125458077, transcript variant X1
progesterone receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 165 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
progesterone receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 165 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
progesterone receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 165 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
progesterone receptor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 165 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho GTPase-activating protein 26-like, transcript variant X4
rho GTPase-activating protein 26-like, transcript variant X3
rho GTPase-activating protein 26-like, transcript variant X2
rho GTPase-activating protein 26-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 26-like isoform X4
rho GTPase-activating protein 26-like isoform X3
rho GTPase-activating protein 26-like isoform X2
rho GTPase-activating protein 26-like isoform X1
rho GTPase-activating protein 26-like, transcript variant X5
rho GTPase-activating protein 26-like isoform X5
polypeptide N-acetylgalactosaminyltransferase 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 10-like
microfibrillar-associated protein 3-like, transcript variant X4
microfibrillar-associated protein 3-like, transcript variant X5
microfibrillar-associated protein 3-like, transcript variant X3
microfibrillar-associated protein 3-like, transcript variant X2
microfibrillar-associated protein 3-like, transcript variant X1
microfibrillar-associated protein 3-like
family with sequence similarity 114 member A2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
family with sequence similarity 114 member A2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
family with sequence similarity 114 member A2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
family with sequence similarity 114 member A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
family with sequence similarity 114 member A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
family with sequence similarity 114 member A2, transcript variant X5
CCR4-NOT transcription complex, subunit 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CCR4-NOT transcription complex, subunit 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
CCR4-NOT transcription complex, subunit 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
CCR4-NOT transcription complex, subunit 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 8 isoform X1
CCR4-NOT transcription complex subunit 8 isoform X2
mothers against decapentaplegic homolog 5, transcript variant X2
mothers against decapentaplegic homolog 5, transcript variant X1
mothers against decapentaplegic homolog 5
short transient receptor potential channel 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X2
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X3
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
kelch-like protein 3, transcript variant X10
kelch-like protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch-like protein 3, transcript variant X2
kelch-like protein 3, transcript variant X3
kelch-like protein 3, transcript variant X1
kelch-like protein 3, transcript variant X9
kelch-like protein 3, transcript variant X7
kelch-like protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kelch-like protein 3, transcript variant X8
kelch-like protein 3, transcript variant X5
heterogeneous nuclear ribonucleoprotein A3-like
neuropeptide Y receptor type 6-like, transcript variant X1
neuropeptide Y receptor type 6-like, transcript variant X2
neuropeptide Y receptor type 6-like, transcript variant X3
polycystic kidney disease 2-like 2 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
protein FAM13B-like, transcript variant X4
protein FAM13B-like, transcript variant X2
protein FAM13B-like, transcript variant X3
protein FAM13B-like, transcript variant X1
thymosin beta-11-like, transcript variant X1
thymosin beta-11-like, transcript variant X2
guanine nucleotide-binding protein subunit beta-2-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein D0-like
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X1
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X2
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X3
dual specificity protein kinase CLK4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
dual specificity protein kinase CLK4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
dual specificity protein kinase CLK4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dual specificity protein kinase CLK4-like isoform X1
dual specificity protein kinase CLK4-like isoform X2
ras-GEF domain-containing family member 1C-like, transcript variant X2
ras-GEF domain-containing family member 1C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ras-GEF domain-containing family member 1C-like
mitogen-activated protein kinase 9, transcript variant X7
mitogen-activated protein kinase 9, transcript variant X6
mitogen-activated protein kinase 9, transcript variant X8
mitogen-activated protein kinase 9, transcript variant X1
mitogen-activated protein kinase 9, transcript variant X2
mitogen-activated protein kinase 9, transcript variant X4
mitogen-activated protein kinase 9, transcript variant X3
mitogen-activated protein kinase 9 isoform X1
mitogen-activated protein kinase 9 isoform X2
mitogen-activated protein kinase 9 isoform X4
mitogen-activated protein kinase 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mitogen-activated protein kinase 9 isoform X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CCR4-NOT transcription complex subunit 6, transcript variant X4
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X3
CCR4-NOT transcription complex subunit 6 isoform X1
CCR4-NOT transcription complex subunit 6 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 2-like, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 2-like isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 2-like isoform X2
eukaryotic translation initiation factor 4E-binding protein 3-like
ankyrin repeat and KH domain containing 1, transcript variant X14
ankyrin repeat and KH domain containing 1, transcript variant X10
ankyrin repeat and KH domain containing 1, transcript variant X15
ankyrin repeat and KH domain containing 1, transcript variant X9
ankyrin repeat and KH domain containing 1, transcript variant X8
ankyrin repeat and KH domain containing 1, transcript variant X7
ankyrin repeat and KH domain containing 1, transcript variant X6
ankyrin repeat and KH domain containing 1, transcript variant X13
ankyrin repeat and KH domain containing 1, transcript variant X12
ankyrin repeat and KH domain containing 1, transcript variant X3
ankyrin repeat and KH domain containing 1, transcript variant X5
ankyrin repeat and KH domain containing 1, transcript variant X4
ankyrin repeat and KH domain containing 1, transcript variant X11
ankyrin repeat and KH domain containing 1, transcript variant X2
ankyrin repeat and KH domain containing 1, transcript variant X1
ankyrin repeat and KH domain-containing protein 1 isoform X14
ankyrin repeat and KH domain-containing protein 1 isoform X10
ankyrin repeat and KH domain-containing protein 1 isoform X15
ankyrin repeat and KH domain-containing protein 1 isoform X9
ankyrin repeat and KH domain-containing protein 1 isoform X8
ankyrin repeat and KH domain-containing protein 1 isoform X7
ankyrin repeat and KH domain-containing protein 1 isoform X6
ankyrin repeat and KH domain-containing protein 1 isoform X13
ankyrin repeat and KH domain-containing protein 1 isoform X12
ankyrin repeat and KH domain-containing protein 1 isoform X3
ankyrin repeat and KH domain-containing protein 1 isoform X5
ankyrin repeat and KH domain-containing protein 1 isoform X4
ankyrin repeat and KH domain-containing protein 1 isoform X11
ankyrin repeat and KH domain-containing protein 1 isoform X2
ankyrin repeat and KH domain-containing protein 1 isoform X1
electrogenic sodium bicarbonate cotransporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H1, like, transcript variant X2
heterogeneous nuclear ribonucleoprotein H1, like, transcript variant X1
heterogeneous nuclear ribonucleoprotein H1, like
RUN and FYVE domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RUN and FYVE domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RUN and FYVE domain-containing protein 1-like isoform X2
RUN and FYVE domain-containing protein 1-like isoform X1
proheparin-binding EGF-like growth factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X5
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X6
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X2
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X1
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X3
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X8
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X7
prostate androgen-regulated mucin-like protein 1 homolog, transcript variant X9
prostate androgen-regulated mucin-like protein 1 homolog isoform X1
uncharacterized serine-rich protein C215.13-like isoform X3
uncharacterized serine-rich protein C215.13-like isoform X2
purine-rich element binding protein Aa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
purine-rich element binding protein Aa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
PH and SEC7 domain-containing protein 2-like, transcript variant X1
PH and SEC7 domain-containing protein 2-like isoform X1
PH and SEC7 domain-containing protein 2-like, transcript variant X2
PH and SEC7 domain-containing protein 2-like isoform X2
uncharacterized LOC125458119, transcript variant X2
uncharacterized LOC125458119, transcript variant X1
uncharacterized LOC125458119, transcript variant X3
CXXC finger protein 5a, transcript variant X12
CXXC finger protein 5a, transcript variant X10
CXXC finger protein 5a, transcript variant X8
CXXC finger protein 5a, transcript variant X1
CXXC finger protein 5a, transcript variant X7
CXXC finger protein 5a, transcript variant X6
CXXC finger protein 5a, transcript variant X4
CXXC finger protein 5a, transcript variant X3
CXXC finger protein 5a, transcript variant X11
CXXC finger protein 5a, transcript variant X5
CXXC finger protein 5a, transcript variant X13
CXXC finger protein 5a, transcript variant X14
CXXC finger protein 5a, transcript variant X2
CXXC finger protein 5a, transcript variant X9
CDGSH iron-sulfur domain-containing protein 1-like
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X3
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X4
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X2
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X1
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast), transcript variant X5
ubiquitin-conjugating enzyme E2 D2 isoform X3
ubiquitin-conjugating enzyme E2 D2 isoform X2
ubiquitin-conjugating enzyme E2 D2 isoform X1
ubiquitin-conjugating enzyme E2 D2 isoform X4
ubiquitin-conjugating enzyme E2 D2 isoform X5
nuclear factor NF-kappa-B p105 subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X1
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X3
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X2
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X4
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X5
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant X6
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X5
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X6
stimulator of interferon response cGAMP interactor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
stimulator of interferon response cGAMP interactor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
stimulator of interferon response cGAMP interactor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
stimulator of interferon response cGAMP interactor 1, transcript variant X3
stimulator of interferon genes protein isoform X1
stimulator of interferon response cGAMP interactor 1, transcript variant X5
stimulator of interferon genes protein isoform X2
endothelial cell surface expressed chemotaxis and apoptosis regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
endothelial cell-specific chemotaxis regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
uncharacterized LOC125458556, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125458556, transcript variant X3
uncharacterized LOC125458556, transcript variant X4
uncharacterized LOC125458556, transcript variant X1
DNA damage-inducible transcript 4-like protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 18, transcript variant X2
dnaJ homolog subfamily C member 18 isoform X1
dnaJ homolog subfamily C member 18 isoform X2
uncharacterized si:ch73-43g23.1, transcript variant X1
uncharacterized si:ch73-43g23.1, transcript variant X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 23 member 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
glutamate receptor ionotropic, delta-2-like, transcript variant X1
glutamate receptor ionotropic, delta-2-like, transcript variant X2
glutamate receptor ionotropic, delta-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, delta-2-like isoform X1
glutamate receptor ionotropic, delta-2-like isoform X2
glutamate receptor ionotropic, delta-2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PDZ and LIM domain 7, transcript variant X1
PDZ and LIM domain 7, transcript variant X2
PDZ and LIM domain 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
eukaryotic translation initiation factor 4E-1A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GRIN2-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
GRIN2-like protein, transcript variant X1
cadherin related family member 2, transcript variant X2
cadherin related family member 2, transcript variant X1
cadherin-related family member 2 isoform X1
cadherin-related family member 2 isoform X2
ring finger protein 44, transcript variant X1
ring finger protein 44, transcript variant X2
ring finger protein 44, transcript variant X3
ring finger protein 44, transcript variant X4
ring finger protein 44, transcript variant X6
ring finger protein 44, transcript variant X5
clathrin light chain A-like, transcript variant X1
clathrin light chain A-like, transcript variant X2
HIG1 hypoxia inducible domain family, member 2A
HIG1 domain family member 2A, mitochondrial
NOP16 nucleolar protein homolog (yeast), transcript variant X2
NOP16 nucleolar protein homolog (yeast), transcript variant X1
ADP-ribosylation factor-like protein 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ADP-ribosylation factor-like protein 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ADP-ribosylation factor-like protein 9, transcript variant X3
ADP-ribosylation factor-like protein 9 isoform X2
ADP-ribosylation factor-like protein 9 isoform X1
ADP-ribosylation factor-like protein 9 isoform X3
SUMO interacting motifs containing 1, transcript variant X3
SUMO interacting motifs containing 1, transcript variant X2
SUMO interacting motifs containing 1, transcript variant X4
SUMO interacting motifs containing 1, transcript variant X6
SUMO interacting motifs containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SUMO interacting motifs containing 1, transcript variant X5
SUMO-interacting motif-containing protein 1 isoform X2
uncharacterized protein simc1 isoform X4
SUMO-interacting motif-containing protein 1 isoform X1
SUMO-interacting motif-containing protein 1 isoform X3
uncharacterized LOC125458519, transcript variant X4
uncharacterized LOC125458519, transcript variant X5
uncharacterized LOC125458519, transcript variant X3
uncharacterized LOC125458519, transcript variant X1
uncharacterized LOC125458519, transcript variant X2
uncharacterized LOC125458519, transcript variant X6
uncharacterized LOC125458519, transcript variant X7
histamine H2 receptor-like, transcript variant X1
histamine H2 receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
trypsin inhibitor ClTI-1-like, transcript variant X2
trypsin inhibitor ClTI-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
casein kinase 1, alpha 1, transcript variant X1
casein kinase 1, alpha 1, transcript variant X2
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 128 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X5
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X4
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Rho guanine nucleotide exchange factor (GEF) 37, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
rho guanine nucleotide exchange factor 37
peroxisome proliferator-activated receptor gamma coactivator 1-alpha-like, transcript variant X2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma coactivator 1-alpha-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma coactivator 1-alpha-like isoform X1
peroxisome proliferator-activated receptor gamma coactivator 1-alpha-like isoform X3
peroxisome proliferator-activated receptor gamma coactivator 1-alpha-like isoform X2
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM8-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM8-like isoform X1
E3 ubiquitin-protein ligase TRIM8-like isoform X2
phosphodiesterase 6A, cGMP-specific, rod, alpha, transcript variant X5
phosphodiesterase 6A, cGMP-specific, rod, alpha, transcript variant X3
phosphodiesterase 6A, cGMP-specific, rod, alpha, transcript variant X2
phosphodiesterase 6A, cGMP-specific, rod, alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 6A, cGMP-specific, rod, alpha, transcript variant X4
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X2
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X3
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X1
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha isoform X4
solute carrier family 26 member 2, transcript variant X2
solute carrier family 26 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
endoplasmic reticulum-golgi intermediate compartment 1
endoplasmic reticulum-Golgi intermediate compartment protein 1
neuralized E3 ubiquitin protein ligase 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase NEURL1B isoform X1
uncharacterized LOC125458511, transcript variant X3
uncharacterized LOC125458511, transcript variant X1
uncharacterized LOC125458511, transcript variant X2
neuralized E3 ubiquitin protein ligase 1B, transcript variant X3
neuralized E3 ubiquitin protein ligase 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEURL1B isoform X2
E3 ubiquitin-protein ligase NEURL1B isoform X3
SH3 and PX domains 2B, transcript variant X1
SH3 and PX domains 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SH3 and PX domains 2B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SH3 and PX domains 2B, transcript variant X3
SH3 and PX domain-containing protein 2B isoform X4
SH3 and PX domain-containing protein 2B isoform X2
SH3 and PX domain-containing protein 2B isoform X3
SH3 and PX domain-containing protein 2B isoform X1
serine/threonine kinase 10, transcript variant X3
serine/threonine kinase 10, transcript variant X2
serine/threonine kinase 10, transcript variant X1
serine/threonine kinase 10, transcript variant X4
serine/threonine-protein kinase 10 isoform X2
serine/threonine-protein kinase 10 isoform X1
serine/threonine-protein kinase 10 isoform X3
EF-hand calcium-binding domain-containing protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC125458391, transcript variant X2
uncharacterized LOC125458391, transcript variant X1
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X2
SH3 domain and tetratricopeptide repeat-containing protein 2-like isoform X1
SH3 domain and tetratricopeptide repeat-containing protein 2-like isoform X2
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X4
SH3 domain and tetratricopeptide repeat-containing protein 2-like isoform X3
SH3 domain and tetratricopeptide repeat-containing protein 2-like, transcript variant X3
actin binding LIM protein family, member 3, transcript variant X1
actin binding LIM protein family, member 3, transcript variant X3
actin binding LIM protein family, member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X6
actin binding LIM protein family, member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X8
actin binding LIM protein family, member 3, transcript variant X9
actin binding LIM protein family, member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
actin binding LIM protein family, member 3, transcript variant X4
actin filament associated protein 1-like 1a, transcript variant X2
actin filament-associated protein 1-like 1 isoform X2
actin filament associated protein 1-like 1a, transcript variant X1
actin filament-associated protein 1-like 1 isoform X1
grpE protein homolog 2, mitochondrial-like, transcript variant X3
grpE protein homolog 2, mitochondrial-like, transcript variant X4
grpE protein homolog 2, mitochondrial-like, transcript variant X1
grpE protein homolog 2, mitochondrial-like isoform X1
grpE protein homolog 2, mitochondrial-like, transcript variant X2
grpE protein homolog 2, mitochondrial-like isoform X2
prenylcysteine oxidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
prenylcysteine oxidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
D(1) dopamine receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
D(1) dopamine receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neuronal vesicle trafficking associated 2, transcript variant X1
neuronal vesicle trafficking associated 2, transcript variant X2
neuronal vesicle trafficking associated 2, transcript variant X4
neuronal vesicle trafficking associated 2, transcript variant X3
neuronal vesicle trafficking-associated protein 2
PTTG1 regulator of sister chromatid separation, securin, transcript variant X1
PTTG1 regulator of sister chromatid separation, securin, transcript variant X4
PTTG1 regulator of sister chromatid separation, securin, transcript variant X2
PTTG1 regulator of sister chromatid separation, securin, transcript variant X3
PTTG1 regulator of sister chromatid separation, securin, transcript variant X5
ribosomal protein L26, transcript variant X1
ribosomal protein L26, transcript variant X2
creb3 regulatory factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
creb3 regulatory factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
creb3 regulatory factor, transcript variant X5
creb3 regulatory factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
creb3 regulatory factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
biorientation of chromosomes in cell division 1, transcript variant X1
biorientation of chromosomes in cell division 1, transcript variant X2
biorientation of chromosomes in cell division protein 1 isoform X1
biorientation of chromosomes in cell division protein 1 isoform X2
uncharacterized LOC125458127, transcript variant X1
uncharacterized LOC125458127, transcript variant X2
cytoplasmic polyadenylation element binding protein 4b, transcript variant X1
cytoplasmic polyadenylation element binding protein 4b, transcript variant X2
cytoplasmic polyadenylation element-binding protein 4b isoform X1
cytoplasmic polyadenylation element-binding protein 4b isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
gastrotropin-like, transcript variant X2
gastrotropin-like, transcript variant X1
PWWP domain containing 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X1
PWWP domain containing 2A, transcript variant X4
PWWP domain-containing protein 2A isoform X3
PWWP domain-containing protein 2A isoform X1
PWWP domain containing 2A, transcript variant X3
PWWP domain-containing protein 2A isoform X2
tetratricopeptide repeat domain 1, transcript variant X3
tetratricopeptide repeat domain 1, transcript variant X2
tetratricopeptide repeat domain 1, transcript variant X1
tetratricopeptide repeat protein 1 isoform X2
tetratricopeptide repeat protein 1 isoform X1
tetratricopeptide repeat protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
catenin (cadherin-associated protein), alpha 1
leucine rich repeat transmembrane neuronal 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
leucine-rich repeat transmembrane neuronal protein 2
pantothenate kinase 3, transcript variant X1
pantothenate kinase 3, transcript variant X2
pantothenate kinase 3, transcript variant X3
single-stranded DNA binding protein 1, transcript variant X1
single-stranded DNA binding protein 1, transcript variant X2
single-stranded DNA-binding protein, mitochondrial
soluble guanylate cyclase 88E-like, transcript variant X4
soluble guanylate cyclase 88E-like, transcript variant X3
soluble guanylate cyclase 88E-like, transcript variant X2
soluble guanylate cyclase 88E-like, transcript variant X1
soluble guanylate cyclase 88E-like isoform X4
soluble guanylate cyclase 88E-like isoform X3
soluble guanylate cyclase 88E-like isoform X2
soluble guanylate cyclase 88E-like isoform X1
G protein-coupled receptor kinase 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G protein-coupled receptor kinase 6-like, transcript variant X2
G protein-coupled receptor kinase 6-like isoform X1
G protein-coupled receptor kinase 6-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin interaction motif containing 1
polyadenylate-binding protein-interacting protein 2-like, transcript variant X2
polyadenylate-binding protein-interacting protein 2-like, transcript variant X1
polyadenylate-binding protein-interacting protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Kv channel-interacting protein 1, transcript variant X2
Kv channel-interacting protein 1, transcript variant X1
Kv channel-interacting protein 1, transcript variant X4
Kv channel-interacting protein 1, transcript variant X5
Kv channel-interacting protein 1, transcript variant X3
Kv channel-interacting protein 1 isoform X2
Kv channel-interacting protein 1 isoform X1
Kv channel-interacting protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kazal-type serine protease inhibitor domain-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: kazal-type serine protease inhibitor domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
T-cell leukemia homeobox protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
T-cell leukemia homeobox protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
T-cell leukemia homeobox protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
T-cell leukemia homeobox protein 3-like isoform X1
T-cell leukemia homeobox protein 3-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein K02A2.6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 13% coverage of the annotated genomic feature by RNAseq alignments
nucleophosmin-like, transcript variant X1
nucleophosmin-like, transcript variant X2
F-box/WD repeat-containing protein 11, transcript variant X1
F-box/WD repeat-containing protein 11, transcript variant X2
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11, transcript variant X4
F-box/WD repeat-containing protein 11, transcript variant X3
F-box/WD repeat-containing protein 11 isoform X3
F-box/WD repeat-containing protein 11 isoform X4
fibroblast growth factor 18-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fibroblast growth factor 18-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor 18-like isoform X1
fibroblast growth factor 18-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
tripartite motif-containing protein 16-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic peptide chain release factor subunit 1, transcript variant X3
eukaryotic peptide chain release factor subunit 1, transcript variant X1
eukaryotic peptide chain release factor subunit 1, transcript variant X2
eukaryotic peptide chain release factor subunit 1
vesicular integral-membrane protein VIP36
programmed cell death protein 4-like, transcript variant X1
programmed cell death protein 4-like, transcript variant X3
programmed cell death protein 4-like, transcript variant X4
programmed cell death protein 4-like, transcript variant X2
programmed cell death protein 4-like isoform X1
programmed cell death protein 4-like isoform X3
programmed cell death protein 4-like isoform X4
programmed cell death protein 4-like isoform X2
serine/threonine-protein kinase 32A-like, transcript variant X2
serine/threonine-protein kinase 32A-like, transcript variant X1
serine/threonine-protein kinase 32A-like, transcript variant X3
serine/threonine-protein kinase 32A-like isoform X2
serine/threonine-protein kinase 32A-like isoform X1
serine/threonine-protein kinase 32A-like isoform X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X4
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X4
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform, transcript variant X5
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
transcription elongation regulator 1b (CA150), transcript variant X4
transcription elongation regulator 1b (CA150), transcript variant X2
transcription elongation regulator 1b (CA150), transcript variant X3
transcription elongation regulator 1b (CA150), transcript variant X1
transcription elongation regulator 1 isoform X4
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
EBF transcription factor 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
EBF transcription factor 1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
EBF transcription factor 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
EBF transcription factor 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
clathrin interactor 1a, transcript variant X1
clathrin interactor 1a, transcript variant X2
U7 snRNA-associated Sm-like protein LSm11
tRNA-histidine guanylyltransferase 1-like, transcript variant X4
tRNA-histidine guanylyltransferase 1-like, transcript variant X2
tRNA-histidine guanylyltransferase 1-like, transcript variant X3
tRNA-histidine guanylyltransferase 1-like, transcript variant X1
tRNA-histidine guanylyltransferase 1-like, transcript variant X5
tRNA-histidine guanylyltransferase 1-like, transcript variant X6
tRNA-histidine guanylyltransferase 1-like, transcript variant X7
probable tRNA(His) guanylyltransferase isoform X2
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X3
probable tRNA(His) guanylyltransferase isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase domain 19b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 19 isoform X1
ADAM metallopeptidase domain 19b, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 19 isoform X2
ubiquitin-like domain containing CTD phosphatase 1
ubiquitin-like domain-containing CTD phosphatase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein INSYN2B-like, transcript variant X2
protein INSYN2B-like, transcript variant X3
protein INSYN2B-like, transcript variant X1
protein INSYN2B-like, transcript variant X5
protein INSYN2B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
sodium-dependent phosphate transport protein 2A-like, transcript variant X3
sodium-dependent phosphate transport protein 2A-like, transcript variant X2
sodium-dependent phosphate transport protein 2A-like, transcript variant X1
sodium-dependent phosphate transport protein 2A-like isoform X2
sodium-dependent phosphate transport protein 2A-like isoform X1
sodium-dependent phosphate transport protein 2A-like isoform X3
regulator of G-protein signaling 14-like, transcript variant X2
regulator of G-protein signaling 14-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulator of G-protein signaling 14-like isoform X2
regulator of G-protein signaling 14-like isoform X1
probable U3 small nucleolar RNA-associated protein 13, transcript variant X1
probable U3 small nucleolar RNA-associated protein 13, transcript variant X2
probable U3 small nucleolar RNA-associated protein 13 isoform X1
probable U3 small nucleolar RNA-associated protein 13 isoform X2
myelin-associated glycoprotein-like, transcript variant X1
myelin-associated glycoprotein-like, transcript variant X2
myelin-associated glycoprotein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins
dihydropyrimidinase-related protein 3-like, transcript variant X1
dihydropyrimidinase-related protein 3-like, transcript variant X3
dihydropyrimidinase-related protein 3-like, transcript variant X4
dihydropyrimidinase-related protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
dihydropyrimidinase-related protein 3-like isoform X1
dihydropyrimidinase-related protein 3-like isoform X3
dihydropyrimidinase-related protein 3-like isoform X4
dihydropyrimidinase-related protein 3-like isoform X2
janus kinase and microtubule-interacting protein 2-like, transcript variant X2
janus kinase and microtubule-interacting protein 2-like isoform X2
janus kinase and microtubule-interacting protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
janus kinase and microtubule-interacting protein 2-like isoform X1
janus kinase and microtubule-interacting protein 2-like, transcript variant X4
janus kinase and microtubule-interacting protein 2-like, transcript variant X3
janus kinase and microtubule-interacting protein 2-like isoform X4
janus kinase and microtubule-interacting protein 2-like isoform X3
synaptonemal complex central element protein 3, transcript variant X2
synaptonemal complex central element protein 3 isoform X2
synaptonemal complex central element protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
synaptonemal complex central element protein 3 isoform X1
synaptonemal complex central element protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
melanin-concentrating hormone receptor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125458303, transcript variant X1
uncharacterized LOC125458303, transcript variant X2
uncharacterized LOC125458303, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00090
fibroblast growth factor receptor-like 1, transcript variant X2
fibroblast growth factor receptor-like 1, transcript variant X1
fibroblast growth factor receptor-like 1, transcript variant X4
fibroblast growth factor receptor-like 1, transcript variant X3
fibroblast growth factor receptor-like 1 isoform X1
fibroblast growth factor receptor-like 1 isoform X2
transmembrane emp24 domain-containing protein 9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
C-terminal-binding protein 1-like, transcript variant X1
C-terminal-binding protein 1-like, transcript variant X2
C-terminal-binding protein 1-like, transcript variant X3
C-terminal-binding protein 1-like isoform X1
C-terminal-binding protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 34% coverage of the annotated genomic feature by RNAseq alignments
M-phase inducer phosphatase 1-B-like, transcript variant X1
M-phase inducer phosphatase 1-B-like isoform X1
M-phase inducer phosphatase 1-B-like, transcript variant X2
M-phase inducer phosphatase 1-B-like isoform X2
GDNF family receptor alpha-4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GDNF family receptor alpha-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
GDNF family receptor alpha-4-like isoform X1
GDNF family receptor alpha-4-like isoform X2
CDC23 (cell division cycle 23, yeast, homolog)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
kinesin family member 20A, transcript variant X1
kinesin family member 20A, transcript variant X3
kinesin family member 20A, transcript variant X2
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 431 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins
Ig heavy chain Mem5-like, transcript variant X3
immunoglobulin heavy constant gamma 2-like, transcript variant X2
immunoglobulin heavy constant gamma 2-like isoform X2
uncharacterized LOC125458298, transcript variant X2
uncharacterized LOC125458298, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC125458298, transcript variant X1
uncharacterized LOC125458298, transcript variant X3
uncharacterized protein LOC125458298 isoform X2
uncharacterized protein LOC125458298 isoform X1
receptor expression-enhancing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
lysine-specific demethylase 3B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
lysine-specific demethylase 3B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
lysine-specific demethylase 3B-like isoform X1
lysine-specific demethylase 3B-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
required for meiotic nuclear division 5 homolog B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
required for meiotic nuclear division 5 homolog B, transcript variant X1
E3 ubiquitin-protein transferase RMND5B isoform X1
E3 ubiquitin-protein transferase RMND5B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NEDD4 binding protein 3, transcript variant X2
NEDD4 binding protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NEDD4 binding protein 3, transcript variant X1
homeodomain-interacting protein kinase 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
docking protein 3-like, transcript variant X1
docking protein 3-like, transcript variant X2
uncharacterized protein LOC125458335 isoform X2
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)
AT-rich interactive domain-containing protein 5B-like, transcript variant X2
AT-rich interactive domain-containing protein 5B-like, transcript variant X1
AT-rich interactive domain-containing protein 5B-like isoform X1
AT-rich interactive domain-containing protein 5B-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125458134, transcript variant X1
uncharacterized LOC125458134, transcript variant X2
fibroblast growth factor receptor 4-like, transcript variant X1
fibroblast growth factor receptor 4-like, transcript variant X2
fibroblast growth factor receptor 4-like isoform X1
fibroblast growth factor receptor 4-like isoform X2
histone-lysine N-methyltransferase NSD2-like
PRELI domain-containing protein 1, mitochondrial-like
lateral signaling target protein 2 homolog, transcript variant X2
lateral signaling target protein 2 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
lateral signaling target protein 2 homolog isoform X2
lateral signaling target protein 2 homolog isoform X1
family with sequence similarity 193 member B, transcript variant X1
family with sequence similarity 193 member B, transcript variant X2
family with sequence similarity 193 member B, transcript variant X3
hepatitis A virus cellular receptor 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52% coverage of the annotated genomic feature by RNAseq alignments